◆英語タイトル:Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8013732
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月21日
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Aviragen Therapeutics Inc (AVIR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus; BTA074, a Phase 2 topical antiviral treatment for genital warts; BTA585, an oral fusion protein inhibitor that Aviragen is developing for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a long-acting neuraminidase inhibitor for influenza A and B infections. The Company also has a preclinical RSV non-fusion inhibitor program for its F-protein inhibitor BTA585. Aviragen is headquartered in Alpharetta, Georgia, the US.
Aviragen Therapeutics Inc Key Recent Developments
Nov 02,2017: Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results
Aug 31,2017: Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results
May 04,2017: Aviragen Therapeutics Reports Third Quarter Fiscal Year 2017 Financial Results
Apr 04,2017: Aviragen Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update
Feb 02,2017: Aviragen Therapeutics Reports Second Quarter Fiscal Year 2017 Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Aviragen Therapeutics Inc – Key Facts 5
Aviragen Therapeutics Inc – Key Employees 6
Aviragen Therapeutics Inc – Key Employee Biographies 7
Aviragen Therapeutics Inc – Major Products and Services 8
Aviragen Therapeutics Inc – History 9
Aviragen Therapeutics Inc – Company Statement 11
Aviragen Therapeutics Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Aviragen Therapeutics Inc – Business Description 13
Aviragen Therapeutics Inc – Corporate Strategy 14
Aviragen Therapeutics Inc – SWOT Analysis 15
SWOT Analysis – Overview 15
Aviragen Therapeutics Inc – Strengths 15
Aviragen Therapeutics Inc – Weaknesses 16
Aviragen Therapeutics Inc – Opportunities 17
Aviragen Therapeutics Inc – Threats 18
Aviragen Therapeutics Inc – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Aviragen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Aviragen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Aviragen Therapeutics Inc, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Nov 02, 2017: Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results 29
Aug 31, 2017: Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results 30
May 04, 2017: Aviragen Therapeutics Reports Third Quarter Fiscal Year 2017 Financial Results 31
Apr 04, 2017: Aviragen Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update 32
Feb 02, 2017: Aviragen Therapeutics Reports Second Quarter Fiscal Year 2017 Financial Results 33
Nov 03, 2016: Aviragen Therapeutics Reports First Quarter Fiscal Year 2017 Financial Results 35
Sep 14, 2016: Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2016 Financial Results 37
Jun 28, 2016: Aviragen Therapeutics Announces the Appointment of Jonas Niaura as Vice President, Corporate Development and Strategy 39
May 05, 2016: Aviragen Therapeutics Reports Third Quarter Fiscal Year 2016 Financial Results 40
Apr 14, 2016: Aviragen Therapeutics to Participate in FBR & Co. Healthcare Series Focused on Infectious Diseases 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47
List of Tables
Aviragen Therapeutics Inc, Key Facts 5
Aviragen Therapeutics Inc, Key Employees 6
Aviragen Therapeutics Inc, Key Employee Biographies 7
Aviragen Therapeutics Inc, Major Products and Services 8
Aviragen Therapeutics Inc, History 9
Aviragen Therapeutics Inc, Other Locations 12
Aviragen Therapeutics Inc, Subsidiaries 12
Aviragen Therapeutics Inc, Key Competitors 19
Aviragen Therapeutics Inc, Ratios based on current share price 20
Aviragen Therapeutics Inc, Annual Ratios 21
Aviragen Therapeutics Inc, Annual Ratios (Cont...1) 22
Aviragen Therapeutics Inc, Interim Ratios 24
Aviragen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Aviragen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Aviragen Therapeutics Inc, Recent Deals Summary 28
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46